Home/Filings/4/0001209191-17-065442
4//SEC Filing

CANNON JAMES ANTHONY 4

Accession 0001209191-17-065442

CIK 0001107421other

Filed

Dec 12, 7:00 PM ET

Accepted

Dec 13, 4:38 PM ET

Size

8.6 KB

Accession

0001209191-17-065442

Insider Transaction Report

Form 4
Period: 2017-12-12
Transactions
  • Exercise/Conversion

    Common Stock

    2017-12-12$2.73/sh+20,000$54,600387,502 total
  • Tax Payment

    Common Stock

    2017-12-12$4.17/sh13,094$54,602374,408 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2017-12-1220,0000 total
    Exercise: $2.73Exp: 2017-12-12Common Stock (20,000 underlying)
Footnotes (2)
  • [F1]Represents shares withheld to pay exercise price.
  • [F2]6,667 shares vested on each of 12/12/08 and 12/12/09; 6,666 shares vested on 12/12/10.

Issuer

ZIOPHARM ONCOLOGY INC

CIK 0001107421

Entity typeother

Related Parties

1
  • filerCIK 0001338533

Filing Metadata

Form type
4
Filed
Dec 12, 7:00 PM ET
Accepted
Dec 13, 4:38 PM ET
Size
8.6 KB